Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Hims & Hers Health
News related to:Hims & Hers Health, Inc · 2 min read
Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Hims & Hers Health, Inc. (HIMS), a publicly traded company listed on the New York Stock Exchange (NYSE: HIMS). The lawsuit, filed on behalf of investors who purchased or acquired HIMS securities between August 4, 2025, and July 29, 2026, alleges that the company engaged in deceptive and unlawful privacy practices.
According to the complaint, HIMS shared consumers' health information with third-party advertising platforms, including Meta Platforms (Facebook and Snap). This practice, the lawsuit claims, subjected HIMS to regulatory scrutiny and increased the risk of significant financial penalties. The company also allegedly misled investors by stating that consumers would be able to consult with a medical provider to find a treatment that is "right for them," while in reality, consumers were being charged for prescriptions almost immediately after submitting an intake form.
The lawsuit was filed in the United States District Court for the Northern District of California and is titled Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313 (N.D. Cal.). Investors have until November 2, 2026, to file for lead plaintiff status.
Kessler Topaz Meltzer & Check, LLP, a nationally recognized securities litigation law firm, is encouraging investors who purchased or acquired HIMS securities during the class period to contact the firm for potential recovery options. The firm offers free case evaluations and representation on a contingency fee basis, meaning there is no cost to the investor if the case is not successful.
The complaint alleges that throughout the class period, HIMS made materially false and misleading statements, and failed to disclose material facts about its business, operations, and prospects. Specifically, the company is accused of failing to disclose that it shared sensitive health information with third-party advertisers, charged consumers for prescriptions almost immediately after submitting an intake form, and was subject to regulatory scrutiny as a result.
Kessler Topaz Meltzer & Check, LLP, has a history of leading significant recoveries in securities litigation and has been recognized for its work in the legal community. The firm's expertise in representing individual and institutional investors makes it well-positioned to guide HIMS investors through the legal process.